Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology

Pulmonary arterial hypertension is an incurable disease marked by dysregulated metabolism, both at the cellular level in the pulmonary vasculature, and at the whole-body level characterized by impaired exercise oxygen consumption. Though both altered pulmonary vascular metabolism and abnormal exercise physiology are key markers of disease severity and pulmonary arterial remodeling, their precise interactions are relatively unknown. Herein we review normal pulmonary vascular physiology and the current understanding of pulmonary vascular cell metabolism and cardiopulmonary response to exercise in Pulmonary arterial hypertension. We additionally introduce a newly developed international collaborative effort aimed at quantifying exercise-induced changes in pulmonary vascular metabolism, which will inform about underlying pathophysiology and clinical management. We support our investigative approach by presenting preliminary data and discuss potential future applications of our research platform.

• Publication year

  2022

• Venue

  Frontiers in Physiology

• Publication date

  2022-09-12

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3389/fphys.2022.963881PMID 36171971PMCID 9510894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.

  2022cited by this paper
• Targeting cancer metabolism in the era of precision oncology

  2021cited by this paper
• Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome

  2021cited by this paper
• Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension.

  2021influential reference
• Metabolism in Pulmonary Hypertension.

  2021cited by this paper
• The magnitude of the Bohr effect profoundly influences the shape and position of the blood oxygen equilibrium curve.

  2020cited by this paper
• Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension

  2020cited by this paper
• Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension

  2020cited by this paper
• Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms

  2020cited by this paper
• Pulmonary vascular and right ventricular burden during exercise in interstitial lung disease.

  2020influential reference
• Publisher Correction: Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment

  2020influential reference
• COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.

  2020cited by this paper
• Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease

  2020influential reference
• Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study

  2020cited by this paper
• Resting Oxygen Consumption and Heart Failure: Importance of Measurement for Determination of Cardiac Output With the Use of the Fick Principle.

  2020cited by this paper
• Incremental Step Test In Patients With Pulmonary Hypertension.

  2020cited by this paper
• Dynamic right ventricular function response to incremental exercise in pulmonary hypertension

  2020cited by this paper
• Sex-related differences in dynamic right ventricular-pulmonary vascular coupling in heart failure with preserved ejection fraction.

  2020cited by this paper
• The hepatic microenvironment uniquely protects leukemia cells through induction of growth and survival pathways mediated by LIPG.

  2020cited by this paper
• Hypoxia‐inducible factor‐1 α deletion in myeloid lineage attenuates hypoxia‐induced pulmonary hypertension

  2019cited by this paper
• Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension

  2019cited by this paper
• Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.

  2019cited by this paper
• Haemodynamic definitions and updated clinical classification of pulmonary hypertension

  2019cited by this paper
• PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension

  2019cited by this paper
• Unexplained exertional intolerance associated with impaired systemic oxygen extraction

  2019cited by this paper
• Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension

  2019cited by this paper
• Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review.

  2019cited by this paper
• High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods.

  2019cited by this paper
• CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension

  2019cited by this paper
• Hallmarks of Endothelial Cell Metabolism in Health and Disease.

  2019cited by this paper
• PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation

  2018cited by this paper
• Pulmonary capillary recruitment in exercise and pulmonary hypertension

  2018cited by this paper
• Emerging therapeutics in pulmonary hypertension.

  2018cited by this paper
• Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension

  2018influential reference
• Pulmonary capillary recruitment in exercise and pulmonary hypertension

  2018cited by this paper
• Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension

  2018cited by this paper
• Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis

  2017influential reference
• Exercise Intolerance in Heart Failure With Preserved Ejection Fraction Diagnosing and Ranking Its Causes Using Personalized O 2 Pathway Analysis

  2017influential reference
• PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.

  2017influential reference
• Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure

  2017cited by this paper
• Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis

  2017cited by this paper
• Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center

  2017cited by this paper
• A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways.

  2017cited by this paper
• Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

  2017cited by this paper
• Right Ventricular-Pulmonary Vascular Interactions.

  2017cited by this paper
• Mechanisms That Modulate Peripheral Oxygen Delivery during Exercise in Heart Failure.

  2017influential reference
• Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients

  2017cited by this paper
• An official European Respiratory Society statement: pulmonary haemodynamics during exercise

  2017cited by this paper
• Targeting Metabolism for Cancer Therapy.

  2017cited by this paper
• Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.

  2016cited by this paper
• Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

  2016cited by this paper
• Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.

  2016cited by this paper
• Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.

  2016cited by this paper
• Pulmonary haemodynamics during recovery from maximum incremental cycling exercise

  2016cited by this paper
• A guide to immunometabolism for immunologists

  2016cited by this paper
• Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.

  2016cited by this paper
• Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction.

  2016cited by this paper
• 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

  2015cited by this paper
• Dysregulated metabolism contributes to oncogenesis.

  2015cited by this paper
• Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.

  2015cited by this paper
• Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: The Role of Abnormal Peripheral Oxygen Extraction

  2015influential reference
• Criteria for diagnosis of exercise pulmonary hypertension

  2015cited by this paper
• Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.

  2015cited by this paper
• Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics

  2015cited by this paper
• Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.

  2014cited by this paper
• Determinants of Right Ventricular Afterload (2013 Grover Conference Series)

  2014cited by this paper
• The metabolic basis of pulmonary arterial hypertension.

  2014cited by this paper
• A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis

  2014cited by this paper
• Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension.

  2014cited by this paper
• Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.

  2014cited by this paper
• Shorter Survival in Familial versus Idiopathic Pulmonary Arterial Hypertension is Associated with Hemodynamic Markers of Impaired Right Ventricular Function

  2013cited by this paper
• Zero reference level for right heart catheterisation

  2013cited by this paper
• Role of PFKFB3-driven glycolysis in vessel sprouting.

  2013cited by this paper
• Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects

  2013cited by this paper
• Pulmonary arterial hypertension: epidemiology and registries.

  2013cited by this paper
• Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect

  2013cited by this paper
• Heterogeneity in Lung 18FDG Uptake in Pulmonary Arterial Hypertension: Potential of Dynamic 18FDG Positron Emission Tomography With Kinetic Analysis as a Bridging Biomarker for Pulmonary Vascular Remodeling Targeted Treatments

  2013cited by this paper
• Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension

  2013cited by this paper
• Physiology of the Pulmonary Circulation and the Right Heart

  2013influential reference
• Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

  2012cited by this paper
• Pulmonary circulation at exercise.

  2012cited by this paper
• Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis.

  2012cited by this paper
• A two-way street: reciprocal regulation of metabolism and signalling

  2012cited by this paper
• Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming

  2012cited by this paper
• Modern age pathology of pulmonary arterial hypertension.

  2012cited by this paper
• Pulmonary vascular resistances during exercise in normal subjects: a systematic review

  2011influential reference
• 18FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study

  2011cited by this paper
• ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

  2011cited by this paper
• Fatty Acid Oxidation and Malonyl-CoA Decarboxylase in the Vascular Remodeling of Pulmonary Hypertension

  2010cited by this paper
• Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

  2010cited by this paper
• The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes

  2010cited by this paper
• Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

  2010cited by this paper
• Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α‐targeted overexpression of the serotonin transporter

  2009cited by this paper
• Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

  2009influential reference
• Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance.

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• The cancer paradigm of severe pulmonary arterial hypertension.

  2008cited by this paper
• Alterations of cellular bioenergetics in pulmonary artery endothelial cells

  2007cited by this paper

• Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing

  2025influential citation
• Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance

  2025cites this paper
• An Unsupervised Approach to Derive Right Ventricular Pressure–Volume Loop Phenotypes in Pulmonary Hypertension

  2025cites this paper
• Physiologic relevance of the transpulmonary metabolome in connective tissue disease–associated pulmonary vascular disease

  2025cites this paper
• The Diagnostic Approach to Pulmonary Hypertension

  2023cites this paper
• Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension

  2023cites this paper
• Dried blood spot characterization of sex‐based metabolic responses to acute running exercise

  2023cites this paper